• CDR-Life Appoints Björn Peters as Chief Business Officer firstwordpharma
    June 10, 2021
    CDR-Life Inc., a biotherapeutics company developing tumor-specific immunotherapies based on a proprietary antibody platform, today announced the expansion of its leadership team with the appointment of Björn Peters as chief business officer.
  • Boehringer and CDR-Life to develop geographic atrophy therapies pharmaceutical-technology
    May 15, 2020
    Boehringer Ingelheim has signed a collaboration and licensing agreement with CDR-Life for the research and development of antibody fragment-based therapeutics to treat geographic atrophy (GA).
PharmaSources Customer Service